NinePointTwo Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$496K Buy
+16,771
New +$348K 0.2% 41
2023
Q3
Sell
-11,023
Closed -$270K 323
2023
Q2
$270K Buy
+11,023
New +$355K 0.1% 87

Other funds holding TNDM

NinePointTwo Capital's TNDM Position: Q4 2023 in Review

NinePointTwo Capital opened a new position in Tandem Diabetes Care (TNDM) in Q4 2023: 16,771 shares worth $496K. The stake represents 0.2% of the portfolio and ranks #41 among its holdings. This is a return to the name: NinePointTwo Capital previously reported a position in TNDM as recently as Q2 2023.

NinePointTwo Capital first reported a position in TNDM in Q2 2023 and has held it in 2 quarters since. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.

  • NinePointTwo Capital held 16,771 shares of Tandem Diabetes Care worth $496K as of Q4 2023.
  • Tandem Diabetes Care was a new NinePointTwo Capital position in Q4 2023.
  • Tandem Diabetes Care made up 0.2% of NinePointTwo Capital's portfolio in Q4 2023, its #41 holding.
  • NinePointTwo Capital first reported a position in Tandem Diabetes Care in Q2 2023 and has held it in 2 quarters since.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.

Based on NinePointTwo Capital's 13F filing for Q4 2023, filed 14 Feb 2024.